vancomycin has been researched along with Pyoderma Gangrenosum in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, T; Casselman, J; Hostoffer, R; Kim, YM; Saad, A; Tcheurekdjian, H; Toller-Artis, E; Wessell, KR | 1 |
| Cohen, MB; Govindaraj, S; Hekiert, AM; Montone, KT; Palmer, JN | 1 |
| Brown, RE; Graham, D; Lay, L | 1 |
3 other study(ies) available for vancomycin and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Multiple necrotic deep wound infections associated with a subcutaneous immunoglobulin infusion.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Cellulitis; Clindamycin; Combined Modality Therapy; Common Variable Immunodeficiency; Debridement; Drug Substitution; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infusions, Subcutaneous; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Pyoderma Gangrenosum; Reoperation; Staphylococcal Infections; Thienamycins; Vancomycin; Wound Infection | 2015 |
Ecthyma gangrenosum mimicking acute invasive fungal sinusitis in an immunocompromised patient.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Diagnosis, Differential; Ecthyma; Humans; Immunocompromised Host; Linezolid; Male; Mycoses; Nasal Mucosa; Ofloxacin; Oxazolidinones; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyoderma Gangrenosum; Risk Factors; Sinusitis; Vancomycin | 2010 |
Bilateral pyoderma gangrenosum of the hand: treatment with dapsone.
Topics: Aged; Dapsone; Hand Dermatoses; Humans; Male; Potassium Permanganate; Pyoderma Gangrenosum; Silver Sulfadiazine; Vancomycin; Wound Healing | 1993 |